Neurocrine Bioscience buy StockNews.com
Start price
04.08.24
/
50%
€139.75
Target price
04.08.25
-
Performance (%)
-21.11%
End price
05.08.25
€110.25
Summary
This prediction ended on 05.08.25 with a price of €110.25. The prediction for Neurocrine Bioscience disappointed with a performance of -21.11%. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Neurocrine Bioscience | -2.228% | -2.228% | -17.199% |
| iShares Core DAX® | 0.191% | 4.892% | 22.046% |
| iShares Nasdaq 100 | -0.614% | 2.901% | 7.804% |
| iShares Nikkei 225® | 0.599% | 7.404% | 22.218% |
| iShares S&P 500 | -0.036% | 3.489% | 4.833% |
Comments by StockNews_com for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for NBIX provided by MarketBeat
In the thread Trading Neurocrine Bioscience
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€135.45
27.07.24
27.07.24
-
27.07.25
27.07.25
-16.98%
28.07.25
28.07.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€134.65
20.07.24
20.07.24
-
20.07.25
20.07.25
-16.26%
21.07.25
21.07.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€125.00
21.06.24
21.06.24
-
21.06.25
21.06.25
-11.16%
22.06.25
22.06.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€107.85
23.09.23
23.09.23
-
23.09.24
23.09.24
-3.38%
24.09.24
24.09.24